Short-course irradiation as adjuvant treatment of surgically resected single brain metastases

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 2067-2067
Author(s):  
M. A. Alrefae ◽  
D. Roberge ◽  
L. Souhami

2067 Background: Surgical resection followed by whole-brain irradiation is a standard treatment approach for patients with a single brain metastasis from solid tumours. As short-course hypofractionated irradiation has proven equivalent to more protracted schedules for the palliative treatment of brain metastasis, it has been commonly applied in the adjuvant setting. Methods: By reviewing our pathology database, we identified patients having undergone complete neurosurgical resection of a single brain metastasis followed by short-course (4–6 fractions) whole-brain irradiation. Irradiation was delivered using standard lateral-opposed megavoltage radiation portals. Local failure and new brain metastases were identified by chart and imaging study reviews. All outcomes were calculated actuarially. Results: Between March 2000 and August 2005, 50 patients received short-course whole-brain irradiation (20 Gy in 5 fractions in 41 of 50 cases) following complete surgical resection of a single brain metastasis. The most common primary malignancies were lung (66%), breast (14%), and cancer of unknown primary origin (10%). Median age was 60 years. Imaging studies were available for all patients and a preoperative MRI was reviewed in 94% of cases. Median follow-up for living patients was 30.0 months. The median overall survival was 10.92 months (29% at 2 years). Following radiation, failure at the surgical site was seen in 51% and 79% of patients at 1 and 2 years. New metastases elsewhere in the brain developed in 26% and 53% of these patients at 1 and 2 years. Conclusions: When calculated actuarially, local failure and new brain metastases were common following surgery and short-course whole-brain radiation therapy. In part, this may represent inefficacy of the short hypofractionated radiation scheme. Further investigation into the local and systemic treatment of these patients is warranted. No significant financial relationships to disclose.

2013 ◽  
Vol 24 ◽  
pp. ix93
Author(s):  
K. Kawasaki ◽  
K. Yamamoto ◽  
H. Yoshida ◽  
N. Tanaka ◽  
T. Nakagawa ◽  
...  

Cancer ◽  
2011 ◽  
Vol 118 (4) ◽  
pp. 1138-1144 ◽  
Author(s):  
Dirk Rades ◽  
Theo Veninga ◽  
Dagmar Hornung ◽  
Oliver Wittkugel ◽  
Steven E. Schild ◽  
...  

Author(s):  
Hiroki Shirato ◽  
Akio Takamura ◽  
Masayoshi Tomita ◽  
Keishiro Suzuki ◽  
Takashi Nishioka ◽  
...  

In Vivo ◽  
2020 ◽  
Vol 34 (5) ◽  
pp. 2705-2709
Author(s):  
DIRK RADES ◽  
JASPAR WITTELER ◽  
TROELS W. KJAER ◽  
SOEREN TVILSTED ◽  
STEVEN E. SCHILD

2010 ◽  
Vol 21 (1) ◽  
pp. 120-128 ◽  
Author(s):  
Ruifeng Liu ◽  
Xiaohu Wang ◽  
Bin Ma ◽  
Kehu Yang ◽  
Qiuning Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document